About the Company
We do not have any company description for Tricida Inc at the moment.
Please visit https://www.tricida.com/ for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TCDA News
Tricida (NASDAQ: TCDA)
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic ...
Northern District Of California Court Partially Grants Motion To Dismiss Putative Securities Class Action Against Pharmaceutical Company’s CEO
Pardi et al., v. Tricida, Inc., et al., No. 21-cv-00076-HSG (N.D. Cal. Mar. 11, 2024). Plaintiff alleged that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ...
Bakker Juliet Tammenoms's Net Worth
Who is Bakker Juliet Tammenoms? Bakker Juliet Tammenoms has an estimated net worth of $533 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS ...
Longitude Capital Partners II, LLC's Net Worth
Who is Longitude Capital Partners II, LLC? Longitude Capital Partners II, LLC has an estimated net worth of $2.38 Million. This is based on reported shares across multiple companies, which include ...
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
Fulcrum Therapeutics Inc (FULC)
Point72 Asset Management increased stake in Tricida, Inc. ByInvesting.com • Apr 02, 2021 On the 23rd of March, Point72 Asset Management bought 1.3 million Tricida , Inc. (NASDAQ:TCDA ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Snap Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Apple Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
‘Food, Inc. 2’ Review: A Second Course
Share full article “Food, Inc. 2,” directed by Robert Kenner and Melissa Robledo, begins by describing how the last few years have shown the risks of letting a handful of mega-suppliers ...
Tesla, Inc. (TSLA)
Tesla will report Q1 earnings after the bell on Tuesday, giving a much-needed update on the EV maker’s current and future prospects as investor sentiment slides. Tesla (TSLA) is asking ...
Nike Inc. Cl B
Under Armour Inc. Cl C 1.39% $2.9B Under Armour Inc. Cl A 0.74% $2.9B ...
Loading the latest forecasts...